New treatment for oxygen-deprived, slow healing wounds available across the UK

Haemoglobin spray Granulox, which is used in the treatment of chronic wounds, has been added to the NHS Drug Tariff, establishing a new Haemoglobin category. The first of its kind, Granulox is now available on prescription across the UK, infirst Healthcare has announced.  Currently more than 200,000 patients in the UK are living with non-healing wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers and post-surgical wounds. Treating patients with chronic wounds costs the NHS between £2.3 and 3.1 billion a year in associated costs including nursing time, dressings, hospital admissions, pain relief and often unnecessary amputations. Granulox